Inge Marie Svane
Clinical Professor
- Published
The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study
D’souza, M., Nielsen, Dorte Lisbet, Svane, Inge Marie, Iversen, Kasper, Rasmussen, P. V., Madelaire, C., Fosbøl, E., Køber, Lars Valeur, Gustafsson, Finn, Andersson, C., Gislason, Gunnar Hilmar, Torp-Pedersen, Christian & Schou, Morten, 2021, In: European Heart Journal. 42, 16, p. 1621-1631Research output: Contribution to journal › Journal article › Research › peer-review
- Accepted/In press
“One more chance to survive”: the experiences of patients with advanced melanoma and their partners with tumor-infiltrating lymphocyte therapy—a qualitative study and recommendations for future care
Egeler, M. D., Boomstra, E., Rohaan, M. W., Van den Heuvel, N. M. J., Fraterman, I., Delfos, M., van de Poll-Franse, L. V., Borch, T. H., Svane, Inge Marie, Haanen, J. B. A. G., Retèl, V. P. & Boekhout, A. H., 2024, (Accepted/In press) In: Journal of Cancer Survivorship.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma
Eggermont, A. M. M., Meshcheryakov, A., Atkinson, V., Blank, C. U., Mandala, M., Long, G. V., Barrow, C., Di Giacomo, A. M., Fisher, R., Sandhu, S., Kudchadkar, R., Romero, P. L. O., Svane, I. M., Larkin, J., Puig, S., Hersey, P., Quaglino, P., Queirolo, P., Stroyakovskiy, D., Bastholt, L. & 14 others, , 2021, In: European Journal of Cancer. 158, p. 156-168 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The real-world outcome of metastatic melanoma: Unknown primary vs. known cutaneous
Ellebaek, E., Bastholt, L., Schmidt, H., Svane, Inge Marie & dqp123, dqp123, 1 Dec 2019, In: International Journal of Cancer. 145, 11, p. 3173-3174 2 p.Research output: Contribution to journal › Letter › Research › peer-review
- Published
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
Ellebaek, E., Iversen, T. Z., Junker, N., Donia, M., Engell-Noerregaard, L., Met, Özcan, Hølmich, Lisbet Rosenkrantz, Andersen, R. S., Hadrup, S. R., Andersen, M. H., Thor Straten, P. & Svane, Inge Marie, 2012, In: Journal of Translational Medicine. 10, p. 169Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Immunotherapy for metastatic colorectal cancer: Present status and new options
Ellebaek, E., Andersen, M. H., Svane, Inge Marie & Straten, P. T., 2012, In: Scandinavian Journal of Gastroenterology. 47, 3, p. 315-24 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma
Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
The Danish metastatic melanoma database (DAMMED): A nation-wide platform for quality assurance and research in real-world data on medical therapy in Danish melanoma patients
Ellebaek, E., Svane, Inge Marie, Schmidt, H., Haslund, C. A., dqp123, dqp123, Hoejberg, L., Ruhlmann, C., Guldbrandt, L. M., Køhler, U. H. & Bastholt, L., Aug 2021, In: Cancer Epidemiology. 73, 7 p., 101943.Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Seasonal variation in effect of anti-PD-1 initiation on overall survival among patients with advanced melanoma
Ellebaek, E., Schina, A., Schmidt, H., Haslund, C. A., Bastholt, L., Svane, Inge Marie & dqp123, dqp123, 2023, In: Pigment Cell and Melanoma Research. 36, 2, p. 224-231Research output: Contribution to journal › Journal article › Research › peer-review
- Published
Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial
Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Moerch Froesig, T., Munir, S., Hadrup, S. R., Andersen, M. H. & Svane, Inge Marie, 2012, In: Cancer Immunology, Immunotherapy. 61, 10, p. 1791-1804 14 p.Research output: Contribution to journal › Journal article › Research › peer-review
ID: 4054758
Most downloads
-
279
downloads
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
258
downloads
T cell recognition of novel shared breast cancer antigens is frequently observed in peripheral blood of breast cancer patients
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
190
downloads
Survival of metastatic melanoma patients after dendritic cell vaccination correlates with expression of leukocyte phosphatidylethanolamine-binding protein 1/Raf kinase inhibitory protein
Research output: Contribution to journal › Journal article › Research › peer-review
Published